Unannounced FDA inspections have started in India, not China
Regulatory NewsJoanne S. EglovitchBiologics/ biosimilars/ vaccinesBiotechnologyChemistry, Manufacturing and Controls (CMC)ComplianceNorth AmericaPharmaceuticalsQuality Assurance and ControlRegulatory Intelligence/Policy